July 8th 2025
Increased capacity will help Circio progress development of circVec AAV gene therapy and in-vivo cell therapy, with the company setting a goal of selecting its first therapeutic candidate in 2026.
Thermo Fisher Scientific Expands Sterile Drug Product Development and Commercial Manufacturing
December 9th 2020The company is investing in expansion at four sites in the United States, United Kingdom, and Italy, which will include construction of new facilities and addition of sterile and lyophilized filling lines.
CPhI Annual Report Reveals that COVID-19 is Benefitting CDMOs
November 12th 2020Analysis from the CPhI Annual Report has revealed that the global contract services sector is benefitting from a switch toward COVID-19 manufacturing and clinical-stage contracts; however, mega-cap pharma innovation is slowing outsourcing.